Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shruti Lal

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer Research Communications|September 4, 2023
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK InhibitorShruti Lal, Neil E Bhola, Bee-Chun Sun, et al.
Cancer Research|February 19, 2014
HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cellsShruti Lal, Richard A Burkhart, Neil Beeharry, et al.
Molecular Cancer Research : MCR|October 23, 2014
MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic CancerRenee M Tholey, Shruti Lal, Masaya Jimbo, et al.
Molecular Cancer Research : MCR|March 1, 2017
CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal PhenotypeShruti Lal, Edwin C Cheung, Mahsa Zarei, et al.
Molecular Therapy. Nucleic Acids|June 9, 2025
Nanoparticle-formulated mRNA encoding engineered multivalent SIRPα-Fc fusion proteins shows robust anti-cancer activity in preclinical modelsShruti Lal, Adrienne Sallets, Srinivasa R Bandi, et al.
Cancer Research|July 9, 2017
Posttranscriptional Regulation of <i>PARG</i> mRNA by HuR Facilitates DNA Repair and Resistance to PARP InhibitorsSaswati N Chand, Mahsa Zarei, Matthew J Schiewer, et al.
Cancer Biology & Therapy|March 13, 2014
dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trialFlorencia McAllister, Danielle M Pineda, Masaya Jimbo, et al.
Molecular Cancer Research : MCR|May 23, 2013
Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survivalRichard A Burkhart, Yu Peng, Zoë A Norris, et al.
Nature Communications|December 28, 2025
Antibiotic contamination and antimicrobial resistance dynamics in the urban sewage microbiome in IndiaDeepjyoti Paul, Daizee Talukdar, Ramani Shyam Kapuganti, et al.
Cancer Research|June 28, 2017
Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer CellsMahsa Zarei, Shruti Lal, Seth J Parker, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Research Communications|September 4, 2023
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK InhibitorShruti Lal, Neil E Bhola, Bee-Chun Sun, et al.
Cancer Research|February 19, 2014
HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cellsShruti Lal, Richard A Burkhart, Neil Beeharry, et al.
Molecular Cancer Research : MCR|October 23, 2014
MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic CancerRenee M Tholey, Shruti Lal, Masaya Jimbo, et al.
Molecular Cancer Research : MCR|March 1, 2017
CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal PhenotypeShruti Lal, Edwin C Cheung, Mahsa Zarei, et al.
Molecular Therapy. Nucleic Acids|June 9, 2025
Nanoparticle-formulated mRNA encoding engineered multivalent SIRPα-Fc fusion proteins shows robust anti-cancer activity in preclinical modelsShruti Lal, Adrienne Sallets, Srinivasa R Bandi, et al.
Cancer Research|July 9, 2017
Posttranscriptional Regulation of <i>PARG</i> mRNA by HuR Facilitates DNA Repair and Resistance to PARP InhibitorsSaswati N Chand, Mahsa Zarei, Matthew J Schiewer, et al.
Cancer Biology & Therapy|March 13, 2014
dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trialFlorencia McAllister, Danielle M Pineda, Masaya Jimbo, et al.
Molecular Cancer Research : MCR|May 23, 2013
Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survivalRichard A Burkhart, Yu Peng, Zoë A Norris, et al.
Nature Communications|December 28, 2025
Antibiotic contamination and antimicrobial resistance dynamics in the urban sewage microbiome in IndiaDeepjyoti Paul, Daizee Talukdar, Ramani Shyam Kapuganti, et al.
Cancer Research|June 28, 2017
Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer CellsMahsa Zarei, Shruti Lal, Seth J Parker, et al.
Pageof 2